These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12548348)

  • 21. Depression impairs executive functioning in Parkinson disease patients with low educational level.
    Kummer A; Harsányi E; Dias FM; Cardoso F; Caramelli P; Teixeira AL
    Cogn Behav Neurol; 2009 Sep; 22(3):167-72. PubMed ID: 19741326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Unified Parkinson's Disease Rating Scale: validation study of the mentation, behavior, and mood section.
    Starkstein SE; Merello M
    Mov Disord; 2007 Nov; 22(15):2156-61. PubMed ID: 17721877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lung function, pulmonary complications, and mortality after allogeneic blood and marrow transplantation in children.
    Kaya Z; Weiner DJ; Yilmaz D; Rowan J; Goyal RK
    Biol Blood Marrow Transplant; 2009 Jul; 15(7):817-26. PubMed ID: 19539213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Executive dysfunction using behavioral assessment of the dysexecutive syndrome in Parkinson's disease.
    Kamei S; Hara M; Serizawa K; Murakami M; Mizutani T; Ishiburo M; Kawahara R; Takagi Y; Ogawa K; Yoshihashi H; Shinbo S; Suzuki Y; Yamaguchi M; Morita A; Takeshita J; Hirayanagi K
    Mov Disord; 2008 Mar; 23(4):566-73. PubMed ID: 18098279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metric attributes of the unified Parkinson's disease rating scale 3.0 battery: Part I, feasibility, scaling assumptions, reliability, and precision.
    Martinez-Martin P; Forjaz MJ
    Mov Disord; 2006 Aug; 21(8):1182-8. PubMed ID: 16673397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Voiding dysfunction in patients with Parkinson's disease: impact of neurological impairment and clinical parameters.
    Sammour ZM; Gomes CM; Barbosa ER; Lopes RI; Sallem FS; Trigo-Rocha FE; Bruschini H; Srougi M
    Neurourol Urodyn; 2009; 28(6):510-5. PubMed ID: 19191278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visual field analysis in patients with Parkinson's disease.
    Yenice O; Onal S; Midi I; Ozcan E; Temel A; I-Gunal D
    Parkinsonism Relat Disord; 2008; 14(3):193-8. PubMed ID: 17888714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The SCOPA-Motor Scale for assessment of Parkinson's disease is a consistent and valid measure.
    Martínez-Martín P; Benito-León J; Burguera JA; Castro A; Linazasoro G; Martínez-Castrillo JC; Valldeoriola F; Vázquez A; Vivancos F; del Val J; van Blercom N; Frades B
    J Clin Epidemiol; 2005 Jul; 58(7):674-9. PubMed ID: 15939218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Respiratory dysfunction in Parkinson's disease.
    Brown LK
    Clin Chest Med; 1994 Dec; 15(4):715-27. PubMed ID: 7867286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of a new scale for the evaluation of sialorrhea in patients with Parkinson's disease.
    Perez Lloret S; Pirán Arce G; Rossi M; Caivano Nemet ML; Salsamendi P; Merello M
    Mov Disord; 2007 Jan; 22(1):107-11. PubMed ID: 17089393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
    Majumdar S; Sen S; Mandal SK
    J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma levels of lipid peroxides in patients with Parkinson's disease.
    Sanyal J; Bandyopadhyay SK; Banerjee TK; Mukherjee SC; Chakraborty DP; Ray BC; Rao VR
    Eur Rev Med Pharmacol Sci; 2009; 13(2):129-32. PubMed ID: 19499848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tear film tests in Parkinson's disease patients.
    Tamer C; Melek IM; Duman T; Oksüz H
    Ophthalmology; 2005 Oct; 112(10):1795. PubMed ID: 16095705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silent aspiration in Parkinson's disease patients with diurnal sialorrhea.
    Nóbrega AC; Rodrigues B; Melo A
    Clin Neurol Neurosurg; 2008 Feb; 110(2):117-9. PubMed ID: 18023964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic and pharmacodynamic comparison of ropinirole 24-hour prolonged release and ropinirole immediate release in patients with Parkinson's disease.
    Tompson D; Oliver-Willwong R
    Clin Neuropharmacol; 2009; 32(3):140-8. PubMed ID: 18978485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
    Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
    J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors predicting response to dopaminergic treatment for resting tremor of Parkinson's disease.
    Sung YH; Chung SJ; Kim SR; Lee MC
    Mov Disord; 2008 Jan; 23(1):137-40. PubMed ID: 17987649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relation of testosterone levels with fatigue and apathy in Parkinson's disease.
    Kenangil G; Orken DN; Ur E; Forta H; Celik M
    Clin Neurol Neurosurg; 2009 Jun; 111(5):412-4. PubMed ID: 19131155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bilateral subthalamotomy in Parkinson's disease: initial and long-term response.
    Alvarez L; Macias R; Lopez G; Alvarez E; Pavon N; Rodriguez-Oroz MC; Juncos JL; Maragoto C; Guridi J; Litvan I; Tolosa ES; Koller W; Vitek J; DeLong MR; Obeso JA
    Brain; 2005 Mar; 128(Pt 3):570-83. PubMed ID: 15689366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.